You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
"profile_description": "Consensus calls from strelka2, mutect2, lancet, and VarDict Java. Two or more callers required to pass, < 0.001 frequency in gnomAD, and min read depth 8 in normal sample, unless in a TERT promoter region or in a hotspot region (see https://www.cancerhotspots.org)",
"profile_description": "Predicted copy number values from WGS (Continuous). Copy number calls obtained using ControlFreeC, filtering calls smaller than 50KB",
"profile_description": "Expression levels from RNA-Seq, Z scores of log2(FPKM + 1) values",
81
+
"genetic_alteration_type": "MRNA_EXPRESSION",
82
+
"datatype": "Z-SCORE",
83
+
"show_profile_in_analysis_tab": "true"
84
+
}
85
+
}
86
+
}
87
+
},
88
+
"merged_fusion": {
89
+
"dir": "merged_fusion",
90
+
"dtypes": {
91
+
"fusion": {
92
+
"ext": "fusions.txt",
93
+
"cbio_name": "data_fusions.txt",
94
+
"meta_file_attr": {
95
+
"stable_id": "fusion",
96
+
"profile_name": "Predicted RNA fusions",
97
+
"profile_description": "Fusion data using arriba and STAR Fusion, annotated and filtered using annoFuse.",
98
+
"genetic_alteration_type": "FUSION",
99
+
"datatype": "FUSION",
100
+
"show_profile_in_analysis_tab": "true"
101
+
}
102
+
}
103
+
}
104
+
},
105
+
"data_sheets": {
106
+
"dir": "datasheets",
107
+
"dtypes": {
108
+
"patient": {
109
+
"cbio_name": "data_clinical_patient.txt",
110
+
"meta_file_attr": {
111
+
"genetic_alteration_type": "CLINICAL",
112
+
"datatype": "PATIENT_ATTRIBUTES"
113
+
}
114
+
},
115
+
"sample": {
116
+
"cbio_name": "data_clinical_sample.txt",
117
+
"meta_file_attr": {
118
+
"genetic_alteration_type": "CLINICAL",
119
+
"datatype": "SAMPLE_ATTRIBUTES"
120
+
}
121
+
}
122
+
}
123
+
},
124
+
"study": {
125
+
"_comment": "If a big study being split into many, make cancer_study_identifer blank, dx will be used",
126
+
"description": "Oligodendroglioma (oligo) is a primary malignant brain cancer that develops from oligodendrocytes. Oligodendroglioma is one of the more common types of glioma (which also includes glioblastoma multiforme and astrocytoma). It is a rare tumor that strikes people of all ages; on average, 1,500 new cases are diagnosed per year in the United States. Rarely, families with multiple affected members have been reported, suggesting that a predisposition for oligodendroglioma can be inherited from blood relatives. Because oligodendroglioma is so rare, it has not been well-studied, due in part to a lack of available biospecimens and data for research use. In collaboration and partnerships with Oligo Nation, CBTN or The Children's Brain Tumor Network and University of Pennsylvania, data types within this project encompass matched tumor/normal whole genome data (WGS), RNA-seq, and longitudinal clinical data. For updates, please see here: <a href=\"https://tinyurl.com/55cxz9am\">Release Notes</a>",
0 commit comments